Improving cancer prevention and care for people living with HIV
Consortium for Advancing Management and Prevention of Cancer in People with HIV
Testing new ways to prevent and treat cancers that occur in people living with HIV, while studying how those cancers start and progress.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11406612 on NIH RePORTER |
What this research studies
If you are living with HIV, this consortium runs clinical trials that test new treatments and prevention approaches for cancers that affect people with HIV, such as anal cancer. The program is a network of hospitals and research centers in the U.S., sub‑Saharan Africa, and Latin America that enrolls patients into treatment and prevention trials and collects biological samples for lab studies. Researchers also work with community advisors and cancer survivors to shape study plans and outreach. Participation can include drug or vaccine trials, screening and surveillance studies, and collection of tissue or blood samples for research.
Who could benefit from this research
Good fit: People living with HIV who have or are at risk for HIV‑associated cancers (for example anal cancer) and who can attend one of the consortium's clinical sites would be the ideal candidates.
Not a fit: People without HIV or those with cancers not linked to HIV are unlikely to qualify for these trials or gain direct benefit from this consortium's studies.
Why it matters
Potential benefit: If successful, the work could lead to better ways to prevent, detect, and treat cancers in people living with HIV and reduce related sickness and deaths.
How similar studies have performed: Yes — the consortium has run dozens of interventional trials with thousands of participants and produced results that have changed care guidelines in both high‑ and low‑resource settings.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.